Analysis of our in-house TNBC cohort samples indicated that lymph node metastatic tumors exhibited a greater expression of MAP7D3 than their corresponding primary tumors (Fig. 5B). The gene discussed is MAP7D3; the disease is metastatic malignant neoplasm in the lymph nodes.